J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests


Pfizer-BioNTech Covid-19 vaccines at a senior living facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021.

Hannah Beier | Bloomberg | Getty Images

Johnson & Johnson Covid-19 vaccine recipients are better off getting a booster shot from Pfizer or Moderna, a highly anticipated U.S. study suggested Wednesday.

The study on “mixing and matching” Covid vaccines included more than 450 adults who have received one of the three regimens currently available in the United States: J&J’s, Moderna’s or Pfizer’s. The study hasn’t yet been peer-reviewed.

Volunteers were divided into groups and received an extra shot of their original vaccine or a booster from a different company.

This is a developing story. Please check back for updates.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

NHTSA asks Tesla why it didn't initiate a recall when it pushed safety-related software update

Wed Oct 13 , 2021
A Tesla operating in the vehicle’s driver-assist system known as Autopilot struck a police car March 17, 2021 in Michigan, officials said in a tweet. Michigan State Police A federal vehicle safety authority is asking Tesla to explain why it didn’t initiate a recall when it pushed a safety-related software […]